Cytek Biosciences shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Cytek Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cytek Biosciences held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytek Biosciences by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $4.2k | 832 | 5.05 |
| 2025-06-30 | $967k | 284k | 3.40 |
| 2025-03-31 | $768k | 192k | 4.01 |
| 2024-12-31 | $1.3M | 197k | 6.49 |
| 2024-09-30 | $967k | 175k | 5.54 |
| 2024-06-30 | $1.1M | 199k | 5.58 |
| 2024-03-31 | $833k | 124k | 6.71 |
| 2023-12-31 | $1.1M | 123k | 9.12 |
| 2023-09-30 | $616k | 112k | 5.52 |
| 2023-06-30 | $589k | 64k | 9.19 |
| 2023-03-31 | $589k | 64k | 9.19 |
| 2022-12-31 | $644k | 63k | 10.21 |
| 2022-09-30 | $1.0M | 70k | 14.72 |
| 2022-06-30 | $686k | 64k | 10.73 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas